Antibody Drug Conjugate Market Insights, Applications Analysis, Trending Segments and Forecast to 2027
Antibody Drug Conjugate Market Information by types on the basis of (Monoclonal Antibodies, Linker, Drug/Toxin), Applications (Different types of Cancers) by end users (medical physicist, cancer research scientist, oncologist) – Forecast to 2027
Pune, India – May 3, 2017 /MarketersMedia/ —
Market Scenario:
Antibody Drug Conjugates are ADCs are empowered antibodies (mAbs) designed to harness the targeting ability of monoclonal antibodies by linking them to cell-killing agents. The unique property of ADCs is that it selectively dispatch highly potent cytotoxic anticancer chemotherapies directly to cancer cells while, at the same time, leaving healthy tissue unaffected. The ADCs market has been one of the most actively evolving markets over the course of last few years and comprises a multitude of therapies that can be potentially exploited for a broad range of cancer indications. ADCs for refractory Hodgkin Lymphoma and metastatic breast cancer are already present in market. Besides this, ADCs can be developed for the treatment of cancers including prostate, kidney, pancreas, ovary, lung, colon and skin.
Key Players
• Seattle Genetics (US)
• ImmunoGen, Inc.(US)
• Roche Holding AG (Switzerland)
• Genentech (US)
• Concortis Biotherapeutics (US)
• Agensys, Inc. (US)
• Antikor (UK)
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1113
Segments:
By Applications
o Prostate
o Kidney
o Pancreas
o Ovary
o Lung
o Colon
o Breast
o Skin
o Other Cancers
By Types
o Monoclonal Antibodies
o Linkers
o Drugs/Toxins
By End Users
o Medical Physicist
o Cancer Research Scientist
o Oncologist
Regional Analysis of Antibody Drug Conjugate Market:
Globally North America is the largest market for Antibody Drug Conjugate Market. The North American market for Antibody Drug Conjugate is expected to grow at high CAGR over the forecasted period. Europe is the second-largest market for Antibody Drug Conjugate which is expected to grow at good CAGR.
MRFR Analysis
The market is continuously emerging, and is estimated to continue the same in the near future. This large growth is majorly attributed to increasing change in lifestyle over the globe which is leading to cancer. For instance, unhealthy eating habits are constantly growing in developing countries causing cancer. In addition to that, rise in cancer technology, development of new therapies with the use of targeted monoclonal antibodies is also primarily driving the growth of global Antibody Drug Conjugate market. However, factors such as; diversity of cancerous cell types and antigens and the time required for trial and error methods are inhibiting the growth of this market.
Browse Report @ https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value/Supply Chain Analysis
5.2 Porter’s 5 Forces Analysis
Continue….
The market is classified and analyzed on the basis of various segments including geographies, which consist of; Americas, Europe, Asia-Pacific, and Middle East & Africa. Out of all, North America accounts for the largest share in the market. In addition, Europe and Asia-Pacific is the fastest growing segment in the Antibody Drug Conjugate market, owing to factors such as increasing healthcare expenditure and improving healthcare infrastructures are further spurring the demand of Antibody Drug Conjugate in various regions.
Related Report
Global Vaccine Conjugates Market Information by Type (Haemophilus B, Monovalent, Multivalent, Others), by Indication (Influenza, Pneumococcal, Meningococcal, Others) – Forecast to 2027 https://www.marketresearchfuture.com/reports/vaccine-conjugates-market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
Phone: +1 646 845 9312
For more information, please visit https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market
Source: MarketersMedia
Release ID: 193190
Copyright © 1999-2013 SproutNews.com
